213 related articles for article (PubMed ID: 30935678)
41. Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohort.
Blachier M; Canouï-Poitrine F; Dougados M; Lethuaut A; Fautrel B; Ferkal S; Le Corvoisier P; Farrenq V; Poulain C; Ghaleh B; Bastuji-Garin S; Claudepierre P
Rheumatology (Oxford); 2013 Sep; 52(9):1686-93. PubMed ID: 23764945
[TBL] [Abstract][Full Text] [Related]
42. [SAPHO syndrome--clinical features].
Przepiera-Bedzak H; Brzosko I; Fliciński J; Samborski W; Brzosko M
Pol Arch Med Wewn; 2006 Dec; 116(6):1172-7. PubMed ID: 18634527
[TBL] [Abstract][Full Text] [Related]
43. Identification of subgroups of inflammatory and degenerative MRI findings in the spine and sacroiliac joints: a latent class analysis of 1037 patients with persistent low back pain.
Arnbak B; Jensen RK; Manniche C; Hendricks O; Kent P; Jurik AG; Jensen TS
Arthritis Res Ther; 2016 Oct; 18(1):237. PubMed ID: 27733191
[TBL] [Abstract][Full Text] [Related]
44. FDG PET/CT in Early and Late Stages of SAPHO Syndrome: Two Case Reports With MRI and Bone Scintigraphy Correlation.
Dong A; Bai Y; Cui Y; Zhang J; Zuo C
Clin Nucl Med; 2016 Apr; 41(4):e211-5. PubMed ID: 26359576
[TBL] [Abstract][Full Text] [Related]
45. A statistical symptomatic evaluation on SAPHO syndrome from 56 cases of confirmed diagnosis and 352 cases of non-SAPHO involvement.
Qiu C; Li M; Wu Q; Zhou J; Liu T; Li J; Liu J; Cheng L; Hong Y; Luo D; Yan J; Pan W; Wang Z; Wang Q; Liu X; Wang L
Clin Rheumatol; 2024 May; 43(5):1763-1775. PubMed ID: 38446355
[TBL] [Abstract][Full Text] [Related]
46. [Vertebral destruction with massive pain in the SAPHO syndrome].
Schmitt M
Dtsch Med Wochenschr; 1999 Jul; 124(30):916; author reply 917. PubMed ID: 10464496
[No Abstract] [Full Text] [Related]
47. Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
Zhang LL; Zhao JX; Liu XY
Rheumatol Int; 2012 Jul; 32(7):1963-5. PubMed ID: 21461853
[TBL] [Abstract][Full Text] [Related]
48. SAPHO syndrome treated with pamidronate.
Tehrani R
Indian J Dermatol Venereol Leprol; 2005; 71(4):273-5. PubMed ID: 16394439
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of long-term nonsteroidal antiinflammatory drug treatment on magnetic resonance imaging-determined bone marrow oedema in early, active axial spondyloarthritis patients.
Tang M; Xue L; Shen Y; Bo L; Yang R; Wen J; Zhang Y; Liu Z; Fu J
Clin Rheumatol; 2018 Jan; 37(1):245-250. PubMed ID: 28497237
[TBL] [Abstract][Full Text] [Related]
50. SAPHO: syndrome or concept? Imaging findings.
Earwaker JW; Cotten A
Skeletal Radiol; 2003 Jun; 32(6):311-27. PubMed ID: 12719925
[TBL] [Abstract][Full Text] [Related]
51. Inflammatory and fatty lesions in the spine and sacroiliac joints on whole-body MRI in early axial spondyloarthritis--3-Year data of the ESTHER trial.
Song IH; Hermann KG; Haibel H; Althoff CE; Poddubnyy D; Listing J; Weiß A; Freundlich B; Lange E; Rudwaleit M; Sieper J
Semin Arthritis Rheum; 2016 Feb; 45(4):404-10. PubMed ID: 26519007
[TBL] [Abstract][Full Text] [Related]
52. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
53. SAPHO syndrome: a long-term follow-up study of 120 cases.
Hayem G; Bouchaud-Chabot A; Benali K; Roux S; Palazzo E; Silbermann-Hoffman O; Kahn MF; Meyer O
Semin Arthritis Rheum; 1999 Dec; 29(3):159-71. PubMed ID: 10622680
[TBL] [Abstract][Full Text] [Related]
54. [The importance of bone scintigraphy in the diagnosis of SAPHO syndrome].
Quirico Rodríguez M; Casáns Tormo I; Redal Peña MC; López Castillo V
Rev Esp Med Nucl; 2010; 29(3):127-30. PubMed ID: 20347186
[TBL] [Abstract][Full Text] [Related]
55. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept.
Rudwaleit M; Baraliakos X; Listing J; Brandt J; Sieper J; Braun J
Ann Rheum Dis; 2005 Sep; 64(9):1305-10. PubMed ID: 15778243
[TBL] [Abstract][Full Text] [Related]
56. Successful treatment of SAPHO syndrome with apremilast.
Adamo S; Nilsson J; Krebs A; Steiner U; Cozzio A; French LE; Kolios AGA
Br J Dermatol; 2018 Oct; 179(4):959-962. PubMed ID: 29034454
[TBL] [Abstract][Full Text] [Related]
57. Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study.
Marzo-Ortega H; McGonagle D; O'Connor P; Emery P
Arthritis Rheum; 2001 Sep; 44(9):2112-7. PubMed ID: 11592375
[TBL] [Abstract][Full Text] [Related]
58. Pamidronate treatment in SAPHO syndrome.
Guignard S; Job-Deslandre C; Sayag-Boukris V; Kahan A
Joint Bone Spine; 2002 Jun; 69(4):392-6. PubMed ID: 12184437
[TBL] [Abstract][Full Text] [Related]
59. Is the bullhead sign on bone scintigraphy really common in the patient with SAPHO syndrome? A single-center study of a 16-year experience.
Fu Z; Liu M; Li Z; Fan Y; Zhang J; Zhang X; Li Q
Nucl Med Commun; 2016 Apr; 37(4):387-92. PubMed ID: 26619395
[TBL] [Abstract][Full Text] [Related]
60. [Recurrent multifocal osteomyelitis in the absence of skin disease].
Lamparter S; List-Hellwig E; Basten O
Dtsch Med Wochenschr; 2013 Apr; 138(17):886-90. PubMed ID: 23592345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
